Logo

Liquid Biopsy

News and reporting on cell-free DNA testing.

Natera Builds Data Backing Serial ctDNA Changes to Aid CRC Patient Management, Treatment Decisions
Premium

The company believes its findings are the first to show that quantifying ctDNA changes can stratify high-risk colorectal cancer patients into better and worse prognostic groups.

IVBH Bio Takes Aim at 'High-Impact' Diseases With RNA-Based Liquid Biopsy Incubator
Premium

The three companies within IVBH's "Innovation studio" — LiquidLung, HepGene, and Mammogen — expect to commercialize a series of lab-developed tests in 2023.

Immunis.AI Reaches $40M in Funding, Hits Key Milestones for Liquid Biopsy Platform

The company completed three pivotal studies and will use financing to support development of several cancer tests.

IV BioHoldings Partners With P4 Diagnostix, Unveils 'Bio Innovation Studio'

The partnership with lab partner P4 Diagnostix aims to fast-track liquid biopsy diagnostic tests across pulmonary, metabolic, and women's health diseases.

Data Demonstrates Lucence Liquid Biopsy Test Can Track Treatment-Based ctDNA Changes
Premium

Researchers used the amplicon-based LiquidHallmark test to correlate tumor DNA changes with treatment response.

Sep 21, 2021

Personal Genome Diagnostics, Cleveland Clinic Join Forces to Advance Liquid Biopsy

Sep 20, 2021

European Commission Objects to Illumina Pushing Through Grail Purchase, Mulls Response

Sep 20, 2021

OncoHost Further Assessing Protein Signature for Predicting NSCLC Patients' Immunotherapy Response
Premium

Sep 15, 2021

Molecular Health, Eone-Diagnomics Genome Center Ink Liquid Biopsy Partnership

Sep 14, 2021

Exact Sciences, NSABP Validating Ability of ctDNA Test to Detect MRD in Colorectal Cancer Patients

Sep 2, 2021

AnPac Bio Developing Multi-Cancer Testing Device Based on Biophysical Properties of Blood Components
Premium

Sep 1, 2021

Bionano Genomics, NuProbe Global Collaborate on Reproductive Health, Cancer Liquid Biopsies

Sep 1, 2021

Burning Rock Details Plans for Cancer Monitoring Assay, Adds New Data Supporting Early Detection
Premium

Aug 31, 2021

Oxford BioDynamics Awarded Grant to Apply EpiSwitch to ICI Cancer Therapy Response

Aug 27, 2021

Delfi Diagnostics Tags Lung Cancer as First Target for Fragmentation-Based Liquid Biopsy Tech
Premium

Aug 25, 2021

US Federal Trade Commission Begins Making the Case for Unwinding Illumina's Grail Purchase
Premium

Aug 24, 2021

Genetron Health Posts 38 Percent Revenue Increase in Q2

Aug 23, 2021

AnPac Bio Files Multi-Cancer Detection Device for Registrational Testing With China's NMPA

Aug 20, 2021

European Commission to Investigate Illumina for Closing Grail Deal

Aug 19, 2021

Illumina's 'Maverick' Move Secures Grail Deal But Risks Loom
Premium

Aug 19, 2021

Skin Cancer Dx Firm Speclipse Raises Nearly $8M to Expand Business

Aug 18, 2021

Illumina Acquires Grail Despite Ongoing Regulatory Scrutiny

Aug 18, 2021

Datar Cancer Genetics Expands Business from Treatment Monitoring to Dx and Screening
Premium

Aug 17, 2021

Agilent Technologies Q3 Revenues Rise 26 Percent

Aug 17, 2021

Karius Receives NY State Approval for Infectious Disease Liquid Biopsy Test